Biotech Showcase
09–11 JAN 2012
San Francisco, CA, USA
Parc 55 Wyndham San Francisco - Union Square
Show Web Site
• • • • • • • • • • • • • • • • • • • •
BIO-Europe Spring
17–21 MAR 2012
Amsterdam, The Netherlands
RAI
Show Web Site
PANEL:
MON 17:15-18:15
Level 1, Room E104
The opportunity of community drug development partnerships for personalized oncology and drug development
MODERATOR: John Freshley
• • • • • • • • • • • • • • • • • • • •
AACR Annual Meeting
31 MAR – 04 APR 2012
Chicago, IL, USA
McCormick Place
Show Web Site
BOOTH #4443
POSTERS:
TUE 8:00am–12:00pm
Molecular Targets and Pathways 1 |
Clinical Research 15 | Section 25
#3664 | Breast cancer companion diagnostic platform based on objectively defined tumor co-expression patterns stratifies multiple clinical and therapeutic endpoints comparison to existing molecular subtyping definitions
PRESENTER: Seth Sadis
#3665 | An EMT gene expression diagnostic predicts resistance to EGFR and MEK-targeted therapies in cell lines and patients
PRESENTER: Sean Eddy |
AACR Mechanisms of Resistance
09–12 MAY 2012
San Diego, CA, USA
Show Web Site
POSTER:
10 MAY 2012 | 2:00 - 4:30 pm
A19 | A qPCR assay, OncoScore Colon predicts resistance to cetuximab in formalin-fixed, paraffin-embedded colorectal cancer tissue independent of KRAS status
PRESENTER: Sean Eddy
• • • • • • • • • • • • • • • • • • • •
GLBIO 2012
INDUSTRY TRACK SPONSOR
15–17 MAY 2012
Ann Arbor, MI, USA
Michigan League
Show Web Site
POSTERS:
15 MAY 2012 |5:30 - 7:30 pm
A07 | Discovery of Novel Cancer Genes through Application of Clinical Metadata Ontology
PRESENTER:
Jeff Bonevich
A06 |
Evaluating Predictive Drug Biomarkers Across 31,000 + Clinical Samples
PRESENTER: Ross Patterson
INDUSTRY TRACK PRESENTATION:
16 MAY 2012 | 10:10 - 10:30 am
Compendia Bioscience
PRESENTER: Chris Gates
• • • • • • • • • • • • • • • • • • • •
ASCO Annual Meeting
01–05 JUN 2012
Chicago, IL, USA
McCormick Place
Show Web Site
BOOTH #23088 |
EORTC-NCI-AACR International Symposium on Molecular Targets and Cancer Therapeutics
06-09 NOV 2012
Dublin, Ireland
BOOTH A9
POSTERS:
09 NOV 2012 | 08:30 - 10:30
#492 | Frequency and Co-occurrence of MAPK and PI3K Pathway Driver Mutations to Guide Single-agent and Combination Therapies: an Analysis of Next Generation Sequence Data From 2700 Patients
PRESENTER: Dr. Emma Bowden
#430 | Analysis of 2,700 Cancer Exomes to Identify Novel Cancer Drivers and Therapeutic Opportunities
PRESENTER: John Freshley
Show Web Site
• • • • • • • • • • • • • • • • • • • •
BIO-Europe 2012
12-14 NOV 2012
Hamburg, Germany
Monday, 12 NOV 2012
09:00–10:30
Level 2, Room D
Personalized oncology and next gen cancer drug development
MODERATOR: John Freshley
Show Web Site
• • • • • • • • • • • • • • • • • • • •
Second Annual TCGA Scientific Symposium
27-28 NOV 2012
Crystal City, VA, USA
ORAL PRESENTATION:
28 NOV 2012 | 9:55 - 10:10 am
POSTER:
27 NOV 2012 | 1:30 - 3:00 pm
Analysis of 3,000 Cancer Exomes to Identify Novel Cancer Drivers and Therapeutic Opportunities
PRESENTER: Dr. Nickolay Khazanov
Show Web Site |